The expression levels of FOXP3 in CD8+ T cells were found to be positively associated with the stage of tumour in OC patients which implies that the OC TME may have the capacity to convert CD8+ effector T cells into CD8+FOXP3+ suppressor cells in vivo [62]. The gene discussed is CD8A; the disease is neoplasm.